Literature DB >> 11062949

[Rational use of albumin].

E Sikuler1, A Shapira, S Mor-Yosef, P Shlaeffer, D Slovik, M Brutin, G Gurman.   

Abstract

The use of albumin has been a matter of debate since its introduction in the 1940's. Albumin is not only expensive but may also be harmful when administered inappropriately. Until recently our use of albumin was controlled by a number of authorized physicians who signed all albumin prescriptions. In August 1998, a multidisciplinary team reviewed the indications for albumin use and introduced simple guidelines for its supply and administration. As a result, the use of albumin has decreased by almost 70%. This indicates that rational use of albumin can be achieved by appropriate guidelines, without requiring administrative limitations. We believe that this conclusion holds true for other diagnostic and therapeutic procedures as well.

Mesh:

Substances:

Year:  2000        PMID: 11062949

Source DB:  PubMed          Journal:  Harefuah        ISSN: 0017-7768


  2 in total

1.  Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 Cells.

Authors:  Zhen Yang; Ting Zhou; Yuanchi Cheng; Mingming Li; Xianglin Tan; Feng Xu
Journal:  Front Pharmacol       Date:  2016-11-15       Impact factor: 5.810

Review 2.  Review of the rational use and adverse reactions to human serum albumin in the People's Republic of China.

Authors:  Ting Zhou; Saihua Lu; Xiufeng Liu; Ye Zhang; Feng Xu
Journal:  Patient Prefer Adherence       Date:  2013-11-28       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.